The U.S. Food and Drug Administration (FDA) has approved the MediBeacon® Transdermal Glomerular Filtration Rate (TGFR) System, a first-of-its-kind device for assessing kidney function in patients with both normal and impaired renal function. Developed by INNOVATE Corp. (NYSE: VATE), this innovative system aims to transform diagnostics for chronic kidney disease (CKD), a condition affecting over […]